Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Citigroup Inc.

Acadia Pharmaceuticals
Start price
€20.40
07.08.25 / 50%
Target price
-
07.08.26
Performance (%)
14.41%
Price
€23.34
08:01
Summary
This prediction is currently active. The prediction currently has a performance of 14.41%. This prediction currently runs until 07.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals 8.030% 8.030%
iShares Core DAX® 1.659% 1.586%
iShares Nasdaq 100 0.381% 1.900%
iShares Nikkei 225® 2.102% -1.377%
iShares S&P 500 0.221% 1.258%

Comments by Citigroup_Inc_ for this prediction

In the thread Acadia Pharmaceuticals diskutieren

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for ACAD provided by MarketBeat

Citigroup Inc. 
0
Report Share
07.08.25 Buy 14.41%

Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€14.56
08.08.24
€21.06
08.08.25
43.94%
09.08.25

Citigroup Inc. 
08.08.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€14.59
09.05.24
€27.83
09.05.25
8.26%
10.05.25

Citigroup Inc. 
09.05.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€20.00
13.12.23
€35.17
13.12.24
-17.60%
14.12.24

Citigroup Inc. 
13.12.23 50%